Odile Blanchet

3.4k total citations
55 papers, 1.5k citations indexed

About

Odile Blanchet is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Odile Blanchet has authored 55 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hematology, 15 papers in Genetics and 14 papers in Molecular Biology. Recurrent topics in Odile Blanchet's work include Acute Myeloid Leukemia Research (17 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers) and Chronic Myeloid Leukemia Treatments (6 papers). Odile Blanchet is often cited by papers focused on Acute Myeloid Leukemia Research (17 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers) and Chronic Myeloid Leukemia Treatments (6 papers). Odile Blanchet collaborates with scholars based in France, United Kingdom and United States. Odile Blanchet's co-authors include Norbert Ifrah, Delphine Réa, Martine Gardembas, Philippe Rousselot, Josy Reiffers, Gérald Marit, Françoise Huguet, Laurence Legros, Jean Michel Cayuela and Odile Maarek and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and American Journal of Clinical Nutrition.

In The Last Decade

Odile Blanchet

52 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Odile Blanchet France	20	829	459	432	264	253	55	1.5k
Jin Takeuchi Japan	22	987 1.2×	344 0.7×	448 1.0×	186 0.7×	605 2.4×	94	1.7k
Hiroaki Goto Japan	22	634 0.8×	171 0.4×	485 1.1×	93 0.4×	476 1.9×	157	1.7k
E. Kohne Germany	25	919 1.1×	959 2.1×	546 1.3×	130 0.5×	103 0.4×	112	2.1k
Françoise Picard France	20	920 1.1×	351 0.8×	573 1.3×	55 0.2×	132 0.5×	45	1.3k
Charlotte Guldborg Nyvold Denmark	18	529 0.6×	185 0.4×	364 0.8×	51 0.2×	288 1.1×	73	982
Michael Pfeilstöcker Austria	22	1.9k 2.3×	942 2.1×	594 1.4×	64 0.2×	284 1.1×	83	2.3k
Robert Hast Sweden	23	1.4k 1.7×	587 1.3×	461 1.1×	73 0.3×	184 0.7×	99	2.0k
Masakazu Nitta Japan	21	566 0.7×	386 0.8×	765 1.8×	101 0.4×	53 0.2×	82	1.5k
Mouhab Ayas Saudi Arabia	21	756 0.9×	251 0.5×	316 0.7×	36 0.1×	296 1.2×	92	1.3k
Samir B. Kahwash United States	18	688 0.8×	135 0.3×	308 0.7×	68 0.3×	381 1.5×	97	1.2k

Countries citing papers authored by Odile Blanchet

Since Specialization

Citations

This map shows the geographic impact of Odile Blanchet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Odile Blanchet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Odile Blanchet more than expected).

Fields of papers citing papers by Odile Blanchet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Odile Blanchet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Odile Blanchet. The network helps show where Odile Blanchet may publish in the future.

Co-authorship network of co-authors of Odile Blanchet

This figure shows the co-authorship network connecting the top 25 collaborators of Odile Blanchet. A scholar is included among the top collaborators of Odile Blanchet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Odile Blanchet. Odile Blanchet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Copin, Marie-Christine, et al.. (2025). MtDNA copy number enrichment is associated with poor prognosis and eosinophilic morphology in clear cell renal cell carcinoma. Pathology & Oncology Research. 31. 1612172–1612172.

Brilland, Benoît, Jérémie Riou, Nathalie Merillon, et al.. (2025). Identification of Renal Transcripts Associated with Kidney Function and Prognosis in ANCA-Associated Vasculitis. Journal of the American Society of Nephrology. 37(1). 131–149. 1 indexed citations

Lacombe, Valentin, Emeline Vinatier, Guillaume Roquin, et al.. (2024). Oral vitamin B12 supplementation in pernicious anemia: a prospective cohort study. American Journal of Clinical Nutrition. 120(1). 217–224. 6 indexed citations

Urbanski, G., Floris Chabrun, Carole Lacout, et al.. (2023). An immuno-lipidomic signature revealed by metabolomic and machine-learning approaches in labial salivary gland to diagnose primary Sjögren’s syndrome. Frontiers in Immunology. 14. 1205616–1205616. 3 indexed citations

Bouvier, Anne, Jérémie Riou, Sylvain Thépot, et al.. (2023). Relationship between comorbidities, mutational profile, and outcome after intensive chemotherapy in patients older than 60 years with acute myeloid leukemia: Assessment of different risk scores. American Journal of Hematology. 98(6). 922–931. 3 indexed citations

Brilland, Benoît, Simon Blanchard, Odile Blanchet, et al.. (2023). #4027 KIDNEY INJURY MOLECULE 1 (KIM-1): A POTENTIAL BIOMARKER OF ACUTE KIDNEY INJURY AND TUBULOINTERSTITIAL INJURY IN PATIENTS WITH ANCA-GLOMERULONEPHRITIS. Nephrology Dialysis Transplantation. 38(Supplement_1).

Bouvier, Anne, Jérémie Riou, Sylvain Thépot, et al.. (2019). Quantitative chimerism in CD3-negative mononuclear cells predicts prognosis in acute myeloid leukemia patients after hematopoietic stem cell transplantation. Leukemia. 34(5). 1342–1353. 5 indexed citations

Wargny, Matthieu, Pierre‐Henri Ducluzeau, Jean‐Michel Petit, et al.. (2018). Circulating PCSK9 levels are not associated with the severity of hepatic steatosis and NASH in a high-risk population. Atherosclerosis. 278. 82–90. 32 indexed citations

Willekens, Christophe, Odile Blanchet, Aline Renneville, et al.. (2015). Prospective long-term minimal residual disease monitoring using RQ-PCR in RUNX1-RUNX1T1-positive acute myeloid leukemia: results of the French CBF-2006 trial. Haematologica. 101(3). 328–335. 87 indexed citations

10.

Blanchet, Odile, Pascale Cornillet‐Lefèbvre, Laurence Baranger, et al.. (2012). Routine use of microarray-based gene expression profiling to identify patients with low cytogenetic risk acute myeloid leukemia: accurate results can be obtained even with suboptimal samples. BMC Medical Genomics. 5(1). 6–6. 4 indexed citations

11.

Guièze, Romain, Pascale Cornillet‐Lefèbvre, Bruno Lioure, et al.. (2012). Role of autologous hematopoietic stem cell transplantation according to the NPM1/FLT3‐ITD molecular status for cytogenetically normal AML patients: A GOELAMS study. American Journal of Hematology. 87(12). 1052–1056. 19 indexed citations

12.

Kosmider, Olivier, Éric Delabesse, Véronique Mansat‐De Mas, et al.. (2011). TET2 mutations in secondary acute myeloid leukemias: a French retrospective study. Haematologica. 96(7). 1059–1063. 31 indexed citations

13.

Chevallier, Patrice, Myriam Labopin, Pascal Turlure, et al.. (2011). A new Leukemia Prognostic Scoring System for refractory/relapsed adult acute myelogeneous leukaemia patients: a GOELAMS study. Leukemia. 25(6). 939–944. 91 indexed citations

14.

Tamburini, Jérôme, Caroline Elie, Valérie Bardet, et al.. (2007). Constitutive phosphoinositide 3-kinase/Akt activation represents a favorable prognostic factor in de novo acute myelogenous leukemia patients. Blood. 110(3). 1025–1028. 112 indexed citations

15.

Schmidt, Aline, Odile Blanchet, Mamoun Dib, et al.. (2007). Bone changes in myelofibrosis with myeloid metaplasia: a histomorphometric and microcomputed tomographic study. European Journal Of Haematology. 78(6). 500–509. 18 indexed citations

16.

Rousselot, Philippe, Françoise Huguet, Delphine Réa, et al.. (2006). Imatinib mesylate discontinuation in patients with chronic myelogenous leukemia in complete molecular remission for more than 2 years. Blood. 109(1). 58–60. 387 indexed citations

17.

Ayrault, Olivier, Nathalie Sorel, Paule Seité, et al.. (2006). Expression of the cell cycle regulators p14ARF and p16INK4a in chronic myeloid leukemia. Leukemia Research. 30(10). 1273–1278. 2 indexed citations

18.

François, Sylvie, Éric Delabesse, Laurence Baranger, et al.. (1998). Deregulated expression of theTAL1 gene by t(1;5)(p32;q31) in patient with T-cell acute lymphoblastic leukemia. Genes Chromosomes and Cancer. 23(1). 36–43. 11 indexed citations

19.

Pellier, Isabelle, Xavier Rialland, Sylvie François, et al.. (1996). Myelodysplastic Syndrome with t(5; 12)(q31;p 12-p 13) and Eosinophilia. Journal of Pediatric Hematology/Oncology. 18(3). 285–288. 15 indexed citations

20.

Blanchet, Odile, et al.. (1991). DNA binding of regulatory factors interacting with MHC-class-I gene enhancer correlates with MHC-class-I transcriptional level in class-I-defective cell lines. International Journal of Cancer. 47(S6). 138–145. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact